1-Methyl-4-[3-(1-naphthyloxy)propyl]piperazine

ID: ALA5267271

Chembl Id: CHEMBL5267271

Max Phase: Preclinical

Molecular Formula: C18H24N2O

Molecular Weight: 284.40

Names and Identifiers

Canonical SMILES:  CN1CCN(CCCOc2cccc3ccccc23)CC1

Standard InChI:  InChI=1S/C18H24N2O/c1-19-11-13-20(14-12-19)10-5-15-21-18-9-4-7-16-6-2-3-8-17(16)18/h2-4,6-9H,5,10-15H2,1H3

Standard InChI Key:  UMAVHQYYCPAJTL-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA5267271

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 284.40

Molecular Weight (Monoisotopic): 284.1889

AlogP: 2.86

#Rotatable Bonds: 5

Polar Surface Area: 15.71

Molecular Species: NEUTRAL

HBA: 3

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): 3

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 8.18

CX LogP: 2.73

CX LogD: 1.88

Aromatic Rings: 2

Heavy Atoms: 21

QED Weighted: 0.79

Np Likeness Score: -1.11

References

1. Aranha CMSQ, Reiner-Link D, Leitzbach LR, Lopes FB, Stark H, Fernandes JPS..  (2023)  Multitargeting approaches to cognitive impairment: Synthesis of aryl-alkylpiperazines and assessment at cholinesterases, histamine H₃ and dopamine D₃ receptors.,  78  [PMID:36542960] [10.1016/j.bmc.2022.117132]

Source

Source(1):

• Scientific Literature